Resultats de la cerca - Kim Magee

  • Mostrar 1 - 1 resultats de 1
Refinar resultats
  1. 1
    Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke

    Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant... per Patrick D. Lyden, Kent E. Pryor, Christopher S. Coffey, Merit Cudkowicz, Robin Conwit, Ashutosh P. Jadhav, Robert N. Sawyer, Jan Claassen, Opeolu Adeoye, Shlee Song, Peter Hannon, Natalia S. Rost, Archana Hinduja, Michel T. Torbey, Jin‐Moo Lee, Curtis Benesch, Michael Rippee, Marilyn M. Rymer, Michael T. Froehler, E. Clarke Haley, Mark D. Johnson, Jon Yankey, Kim Magee, Julie C. Qidwai, Howard Levy, E. Mark Haacke, Eliza C. Miller, Thomas P. Davis, Arthur W. Toga, John H. Griffin, Berislav V. Zloković

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: